Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.20
+8.1%
$1.22
$0.84
$2.03
$45.76M0.99119,746 shs154,904 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
$3.57
-1.9%
$3.57
$0.75
$4.31
N/AN/A74,379 shs3,700 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.00%-3.48%-7.50%+2.78%-32.32%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
1.6496 of 5 stars
3.50.00.00.00.63.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00483.24% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
N/AN/AN/AN/A

Current Analyst Ratings

Latest GALXF, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.81N/AN/A$2.97 per share0.40
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
N/AN/A0.00N/AN/AN/AN/AN/A

Latest GALXF, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
N/AN/AN/AN/AN/A

Latest GALXF, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Galaxy Resources Limited stock logo
GALXF
Galaxy Resources
200N/AN/ANot Optionable

GALXF, BOLT, CZX, and FCR Headlines

SourceHeadline
Samsung Galaxy S25 Ultra: All the rumors so farSamsung Galaxy S25 Ultra: All the rumors so far
tomsguide.com - April 20 at 6:51 PM
Galaxy Resources (OTCMKTS:GALXF) Stock Price Passes Below 50 Day Moving Average of $3.57Galaxy Resources (OTCMKTS:GALXF) Stock Price Passes Below 50 Day Moving Average of $3.57
americanbankingnews.com - April 17 at 5:08 AM
Samsung Galaxy Z Fold 6: latest news, rumors, and everything we know so farSamsung Galaxy Z Fold 6: latest news, rumors, and everything we know so far
techradar.com - March 28 at 2:28 AM
Samsung Galaxy S25: what we want to seeSamsung Galaxy S25: what we want to see
techradar.com - March 23 at 8:17 AM
The Galaxy S24s Best Galaxy AI Features: Circle to Search, Live Translate and MoreThe Galaxy S24's Best Galaxy AI Features: Circle to Search, Live Translate and More
cnet.com - March 19 at 8:34 AM
SpaceX: Cellular Starlink System Works on iPhone, Pixel, Galaxy DevicesSpaceX: Cellular Starlink System Works on iPhone, Pixel, Galaxy Devices
msn.com - March 9 at 6:49 PM
Samsung Galaxy Z Flip 6: latest news, rumors, and everything we know so farSamsung Galaxy Z Flip 6: latest news, rumors, and everything we know so far
techradar.com - February 29 at 11:39 PM
Best Samsung Galaxy Z Flip 3 Cases for 2024Best Samsung Galaxy Z Flip 3 Cases for 2024
cnet.com - February 29 at 11:39 PM
The best Guardians of the Galaxy comics & where to find themThe best Guardians of the Galaxy comics & where to find them
dexerto.com - February 26 at 8:35 PM
LA Galaxy break club record with $10m Gabriel Pec transferLA Galaxy break club record with $10m Gabriel Pec transfer
msn.com - January 31 at 10:09 AM
Samsung Galaxy S24 cameras: everything you need to knowSamsung Galaxy S24 cameras: everything you need to know
techradar.com - January 18 at 2:12 PM
LA Galaxy agree club-record transfer for Vascos Gabriel Pec - reportsLA Galaxy agree club-record transfer for Vasco's Gabriel Pec - reports
msn.com - January 11 at 11:23 PM
Samsung Galaxy S24 Ultra specs rumors: everything we know so farSamsung Galaxy S24 Ultra specs rumors: everything we know so far
techradar.com - January 11 at 8:21 AM
Samsung Galaxy S24 specs rumors: everything we know so farSamsung Galaxy S24 specs rumors: everything we know so far
techradar.com - January 11 at 8:21 AM
Samsung Galaxy S24 release date predictionsSamsung Galaxy S24 release date predictions
techradar.com - January 4 at 8:36 AM
5 Reasons to Wait for the Galaxy S24 & 4 Reasons Not To5 Reasons to Wait for the Galaxy S24 & 4 Reasons Not To
gottabemobile.com - December 30 at 12:14 PM
Samsung Galaxy S24 Ultra vs Galaxy S23 Ultra: Biggest upgrades we expectSamsung Galaxy S24 Ultra vs Galaxy S23 Ultra: Biggest upgrades we expect
tomsguide.com - December 14 at 3:37 PM
Samsung Galaxy Fit 3: the latest rumors and what we want to seeSamsung Galaxy Fit 3: the latest rumors and what we want to see
techradar.com - December 12 at 7:48 AM
LA Galaxy name Will Kuntz general managerLA Galaxy name Will Kuntz general manager
mlssoccer.com - December 5 at 6:21 PM
Samsung Galaxy S23 review: Snatch up a BARGAIN this Black FridaySamsung Galaxy S23 review: Snatch up a BARGAIN this Black Friday
expertreviews.co.uk - November 28 at 11:51 PM
Samsung Galaxy S23 Ultra 5GSamsung Galaxy S23 Ultra 5G
digit.in - November 21 at 3:50 PM
Galaxy Gaming Announces Leadership ChangeGalaxy Gaming Announces Leadership Change
markets.businessinsider.com - November 6 at 5:52 PM
Chicharito, LA Galaxy part ways after four seasonsChicharito, LA Galaxy part ways after four seasons
mlssoccer.com - November 4 at 8:18 AM
Science KS1 - Galaxy PugsScience KS1 - Galaxy Pugs
bbc.co.uk - October 27 at 8:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Galaxy Resources logo

Galaxy Resources

OTCMKTS:GALXF
Galaxy Resources Ltd. engages in production of lithium concentrate and exploration of mineral properties. It operates through the following segments: Corporate, Australia, Argentina and Canada. The Australia segment includes the development and operation of the Mt Cattlin spodumene mine, and exploration for minerals. The Argentina segment refers to the development of the Sal de Vida project and exploration for minerals. The Canada segment covers the development of the James Bay project and exploration for minerals. The company was founded on January 15, 1996 and is headquartered in Applecross, Australia.